Professional Marketing brief: September 2012

Professional Marketing brief: September 2012
Professional Marketing brief: September 2012

Novartis and the University of Pennsylvania have created an alliance to research and develop targeted chimeric antigen receptor (CAR) immunotherapies to treat cancer. Novartis gained exclusive rights to the investigational therapy CART-19, which Penn has begun piloting. The experimental treatments target a protein linked to B-cell malignancies such as chronic lymphocytic leukemia and diffuse large B-cell lymphoma.

Johnson & Johnson has reached an agreement in principle regarding Risperdal allegations, the Wall Street Journal reported. The Journal estimates the agreement could hit $2.2 billion. Johnson & Johnson has been sued over alleged infractions that include encouraging off-label use for the anti-psychotic and improper marketing tactics.

GlaxoSmithKline's $3.6-billion offer for Human Genome Sciences came with an added price. As first reported by the Washington Post, upon the closing of the offer, several HGS board members resigned and were replaced with GSK executives. And following the appointment of the GSK designees, “the HGS Board removed all of the executive officers of HGS,” notes the tender offer statement GSK filed with the SEC.
You must be a registered member of MMM to post a comment.

Email Newsletters


As US pharma continued its quest for a Grand Prix at the Lions Health international festival of creativity, MM&M went on location to Cannes, France. Missed our coverage from June? Now, we're giving you an opportunity to catch up on some of what you missed. Download our e-book on the two-day festival, recapping the event, rounding up the best of the speakers, offering perspective and listing all of the winners. Click here to download.


The most recent MM&M Skill Sets Live event surveyed a range of issues relating to one of the hottest promotional spaces in healthcare. Speakers and panelists at the morning-long session, including promotional- and multichannel-minded executives from GSK, Epocrates, Treato and Montefiore Medical Center, weighed in on topics designed to help marketers demystify the challenges associated with non-personal promotion. Click here.